• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 2X40G; BONE CEMENT, ANTIBIOTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. REFOBACIN BONE CEMENT R 2X40G; BONE CEMENT, ANTIBIOTIC Back to Search Results
Model Number N/A
Device Problem Unsealed Device Packaging (1444)
Patient Problems No Consequences Or Impact To Patient (2199); No Known Impact Or Consequence To Patient (2692)
Event Date 10/23/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Report source: foreign.The event occurred in (b)(6).Pma 510(k): the product within this report is a combination product.The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.Not returned to manufacturer.
 
Event Description
It was reported sterile packaging is not fully sealed, resulting in the package contents spilling out so it could not be used anymore.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.Corrective action has been initiated for the reported issue.The device manufacturing quality record indicates that the released product met all requirements to perform as intended.The device analysis can't be performed as the product location is unknown.According to available data, the most probable root cause is due to packaging issue (sealing process).Corrective action has been initiated to address reported issue.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It has been reported that the sterile packaging was not fully sealed, resulting in the package contents spilling out so it could not be used anymore.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It was reported that the sterile packaging was not fully sealed, resulting in the package contents spilling out so it could not be used anymore.The event occured in 3 products.
 
Manufacturer Narrative
(b)(4) this follow-up report is being submitted to relay additional information.The following sections were updated: b4, b5, d10, g4, h1, h2, h3, h6, h10.Three complaint samples were received and evaluated and the reported event was confirmed.Evaluation of returned devices found that the sealings were opened.The device manufacturing quality record indicates that the released product met all requirements to perform as intended.According to available data, the most probable root cause is due to packaging issue (sealing process).Corrective action has been initiated to address reported issue.No similar complaint has been recorded for refobacin bone cement r 2x40g, reference (b)(4), batch a552ck1626 within one year.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
REFOBACIN BONE CEMENT R 2X40G
Type of Device
BONE CEMENT, ANTIBIOTIC
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
MDR Report Key7095656
MDR Text Key94646012
Report Number3006946279-2017-00275
Device Sequence Number1
Product Code MBB
Combination Product (y/n)N
PMA/PMN Number
K150850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Remedial Action Modification/Adjustment
Type of Report Initial,Followup,Followup,Followup
Report Date 01/20/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/07/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2018
Device Model NumberN/A
Device Catalogue Number3003940002
Device Lot NumberA552CK1626
Other Device ID NumberN/A
Was Device Available for Evaluation? Yes
Date Returned to Manufacturer04/26/2018
Was the Report Sent to FDA? No
Date Manufacturer Received01/20/2020
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberN/A
Patient Sequence Number1
Patient Age56 YR
-
-